Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

137 evidence items · page 1 / 6

722,000,000 casD'ici la fin de 2019, plus de 722 millions de cas de COVID-19 avaient été confirmés dans le monde.

MaliCOVID-19observed fin de 2019HAL · Unilimdocument of 36 observations

31.8 %The estimated infection rate of COVID-19 in the Tombouctou population was 31.8% (95% CI: 31.5% to 32.2%).

MaliCOVID-19HAL · Unilimdocument of 88 observations

33.5 %The crude seroprevalence of SARS-CoV-2 was 33.5% among 923 tested participants.

MaliCOVID-19published 2025PLOS global public healtheurope_pmcdocument of 3 observations

10,042 casesAs of 31 March 2021, there were 10,042 cases and 385 deaths from COVID-19 reported in Mali.

MaliCOVID-19observed 31 March 2021HAL · Unilimdocument of 8 observations

80.5 %In COVID-19 patients (n = 266), 80.5% responded to the S antigen.

MaliCOVID-19HAL · Unilimdocument of 67 observations

The duration of treatment was shorter for participants who had higher antibody levels at admission for all three antigens, especially for RBD (p < 0.01).

MaliCOVID-19HAL · Unilimdocument of 67 observations

31.9 %Recognition of the SARS-CoV-2 proteins by sera from COVID-19 patients was 31.9% for RBM.

MaliCOVID-19HAL · Unilimdocument of 67 observations

9.6 %False positivity against the three SARS-CoV-2 antigens was observed in 9.6% to 20.0% of cross-reactive samples from pre-COVID-19 volunteers.

MaliCOVID-19HAL · Unilimdocument of 67 observations

27.1 %Among 266 COVID-19 donor samples, 72 (27.1%) recognized all three antigens (S, RBD, and RBM).

MaliCOVID-19HAL · Unilimdocument of 67 observations

30.1 %In the COVID-19 sample group (N = 266), the prevalence of antibody responders against RBM was 30.1% among males.

MaliCOVID-19 · SARS-CoV-2 RBMHAL · Unilimdocument of 67 observations

20 %The seroprevalence of SARS-CoV-2 in the neighborhoods of the urban commune of Tombouctou varied from 20% to 47%.

MaliCOVID-19HAL · Unilimdocument of 88 observations

0.45 R_valueThere was a significant positive correlation between antibody responses against RBD and RBM (R = 0.45, p = 0.001).

MaliCOVID-19HAL · Unilimdocument of 67 observations

14,000,000 casL’impact des perturbations des centres de santé durant la pandémie de COVID-19 a contribué à l’augmentation considérable de 14 millions de cas entre 2019 et 2020.

MaliCOVID-19 · paludismeobserved 2019–2020HAL · Unilimdocument of 214 observations

Les agents de santé communautaires peuvent suivre avec précision le protocole de dépistage et interpréter correctement les résultats des tests antigéniques rapides pour la COVID-19.

MaliCOVID-19HAL · Unilimdocument of 36 observations

10 %Parmi les 10 patients ayant reçu un Ag-RDT au centre de santé communautaire (CHC) dans le bras SOC, 1 était positif, soit une prévalence de 10 %.

MaliCOVID-19observed June 2022 and September 2022HAL · Unilimdocument of 36 observations

The seroprevalence in the neighborhoods of the urban commune of Tombouctou varied from 20% to 47%.

MaliCOVID-19HAL · Unilimdocument of 88 observations

31.8 %The estimated number of COVID-19 infections in the Tombouctou population was 22,295, representing 31.8% of the population.

MaliCOVID-19HAL · Unilimdocument of 88 observations

2.08 R0The basic reproduction number (R0) for COVID-19 in Tombouctou was estimated at 2.08 [1.46–2.93].

MaliCOVID-19HAL · Unilimdocument of 88 observations

38 yearsThe median age of hospitalized laboratory-confirmed COVID-19 patients was 38.0 years in Mali during March 5, 2020 to May 4, 2021.

MaliCOVID-19observed March 5, 2020 to May 4, 2021HAL · Unilimdocument of 9 observations

The first COVID-19 case diagnosed in Mali was reported on March 25, 2020.

MaliCOVID-19observed March 25, 2020HAL · Unilimdocument of 67 observations

25 %Parmi les patients présentant des symptômes évocateurs de COVID-19 dans l'étude ECoVAM, 25 % ont été testés positifs par test antigénique rapide (Ag-RDT).

MaliCOVID-19HAL · Unilimdocument of 36 observations

81.7 %In the COVID-19 sample group (N = 266), the prevalence of antibody responders against S was 81.7% among females.

MaliCOVID-19 · SARS-CoV-2 S proteinHAL · Unilimdocument of 67 observations

6,981,000 décèsPrès de 6 981 000 décès liés au COVID-19 avaient eu lieu dans le monde d'ici la fin de 2019.

MaliCOVID-19observed fin de 2019HAL · Unilimdocument of 36 observations

2.02 IRRTraditionally Wealth Households (TWH) had an incidence rate ratio of 2.02 for SARS-CoV-2 seropositivity compared to Low-Wealth Households (LWH).

MaliCOVID-19HAL · Unilimdocument of 88 observations

41 %Parmi les 835 patients suspects de COVID-19, 353 (41 %) présentaient des critères mineurs de COVID-19.

MaliCOVID-19observed June 2022 and September 2022HAL · Unilimdocument of 36 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.